Alexa Fluor® 555 Anti-Amylin/DAP 抗体 [EPR22556-138]
Alexa Fluor® 555 Anti-Amylin/DAP antibody [EPR22556-138]
- RabMAb
- Recombinant
- 詳細を見る
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal Amylin/DAP antibody - conjugated to Alexa Fluor® 555.
別名を表示する
Islet amyloid polypeptide, IAPP, Amylin, Diabetes-associated peptide, DAP, Iapp
関連する標識済み抗体及び組成の異なる製品 (10)
-
Anti-Amylin/DAP antibody [EPR22556-138]
-
578 PE
PE Anti-Amylin/DAP antibody [EPR22556-138]
-
HRP Anti-Amylin/DAP antibody [EPR22556-138]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-Amylin/DAP antibody [EPR22556-138]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Amylin/DAP antibody [EPR22556-138]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Amylin/DAP antibody [EPR22556-138]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-Amylin/DAP antibody [EPR22556-138]
-
660 APC
APC Anti-Amylin/DAP antibody [EPR22556-138]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-Amylin/DAP antibody [EPR22556-138]
-
Anti-Amylin/DAP antibody [EPR22556-138] - BSA and Azide free
製品の詳細
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
How are conjugated primary antibodies validated?
This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling.
For suitable applications and species reactivity, please refer to the unconjugated version of this clone.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Amylin peptide regulates blood glucose levels by slowing gastric emptying and promoting satiety. It acts as part of a complex with calcitonin receptor and a receptor activity-modifying protein to mediate its effects efficiently. Amylin influences the central nervous system by affecting appetite and has roles in bone metabolism through interactions with receptors related to alkaline phosphatase 138.
Pathways
Amylin functions in the glucose homeostasis and energy regulation pathways. It closely works with insulin impacting how the body manages postprandial glucose spikes. The peptide also interacts with cAMP signaling which is part of the same network that involves proteins like glucagon-like peptide-1 (GLP-1) which harmonizes action between different metabolic regulatory components.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
Abcam product promise
関連製品
Alternative Version
Primary Antibodies
AB255329
Anti-Amylin/DAP antibody [EPR22556-138] - BSA and Azide free
primary-antibodies
amylin-dap-antibody-epr22556-138-bsa-and-azide-free-ab255329
0
(0 reviews)
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com